Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Nasus Pharma Ltd. before investing.

In this article, we go over a few key elements for understanding Nasus Pharma Ltd.’s stock price such as:

• Nasus Pharma Ltd.’s current stock price and volume
• Why Nasus Pharma Ltd.’s stock price changed recently
• Upgrades and downgrades for NSRX from analysts
• NSRX’s stock price momentum as measured by its relative strength

About Nasus Pharma Ltd. (NSRX)

Before we jump into Nasus Pharma Ltd.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Nasus Pharma Ltd. operates as a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. The company offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company’s products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.

Want to learn more about Nasus Pharma Ltd.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Nasus Pharma Ltd..

Nasus Pharma Ltd.’s Stock Price as of Market Close

As of January 16, 2026, 9:44 AM, CST, Nasus Pharma Ltd.’s stock price was $7.050.

Nasus Pharma Ltd. is down 0.7% from its previous closing price of $7.100.

During the last market session, Nasus Pharma Ltd.’s stock traded between $6.990 and $7.200. Currently, there are approximately 7.36 million shares outstanding for Nasus Pharma Ltd..

Nasus Pharma Ltd.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Nasus Pharma Ltd. Stock Price History

Nasus Pharma Ltd.’s (NSRX) price is currently down 22.95% so far this month.

During the month of January, Nasus Pharma Ltd.’s stock price has reached a high of $9.500 and a low of $6.570.

Over the last year, Nasus Pharma Ltd. has hit prices as high as $9.990 and as low as $5.900. Year to date, Nasus Pharma Ltd.’s stock is down 22.95%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Nasus Pharma Ltd. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of January 16, 2026, there were analysts who downgraded Nasus Pharma Ltd.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Nasus Pharma Ltd.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Nasus Pharma Ltd.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Nasus Pharma Ltd. (NSRX) by visiting AAII Stock Evaluator.

Relative Price Strength of Nasus Pharma Ltd.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 16, 2026, Nasus Pharma Ltd. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.

Want to learn more about how Nasus Pharma Ltd. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Nasus Pharma Ltd. Stock Price: Bottom Line

As of January 16, 2026, Nasus Pharma Ltd.’s stock price is $7.050, which is down 0.7% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Nasus Pharma Ltd. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.